PGNY
Progyny, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$25.94
−2.52%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
18.7x
EV/EBITDA
14.0x
Market Cap
$1.99B
MomentumView details →
1D Return
−2.52%
YTD Return
+1.09%
RSI (14)
41.8
ValuationView details →
P/E (Fwd)
18.7x
EV/EBITDA
14.0x
Market Cap
$1.99B
RSI (14)
41.8
MomentumView details →
1D Return
−2.52%
YTD Return
+1.09%
SummaryUpdated Jun 1, 2026
Progyny, Inc. (NASDAQ:PGNY) is a specialized benefits management company founded in 2008 and headquartered in New York. Originally incorporated as Auxogyn, Inc., the company rebranded to Progyny in 2015 and went public in October 2019. Progyny has established itself as a leading provider of fertility and family building benefits solutions for employers across the United States, serving over 530 clients with approximately 6.7 million covered lives as of 2025.
Similar companies
Latest newsMore news →
Progyny reported Q2 CY2026 revenue of $350.5 million and adjusted EPS of $0.55, beating analyst estimates, but the stock fell in reaction.21d agoProgyny Inc's stock fell 4.6% to $26.55 on August 11, 2026.24d agoProgyny reported Q2 2026 adjusted earnings of $0.55 per share on revenue of $350.51 million, beating analyst estimates of $0.34 and $348.69 million, respectively.29d ago